Skip to main content
Clinical Trials/NCT02991716
NCT02991716
Completed
Not Applicable

Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development

NewPace Ltd1 site in 1 country50 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arrhythmia, Cardiac
Sponsor
NewPace Ltd
Enrollment
50
Locations
1
Primary Endpoint
successful recording of Electrocardiogram (ECG) from a patient containing arrhythmia
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Record cutaneous Electrocardiogram (ECG) data from positions corresponding to the expected subcutaneous locations of the Implantable Subcutaneous String Defibrillator (ISSD) using existing, approved ECG recording devices.

Detailed Description

2 electrodes places near the sternum and 2 near the midaxillary line, simulating the expected positions of Implantable Subcutaneous String Defibrillator (ISSD) sense electrodes. reference ECG electrodes are also attached (in most cases). Approved ECG recording devices are used to record the signal continuously: During an EP session (different types) a bedside recorder, and a holter monitor is used during holter recordings. Ep session recordings are performed in order to capture different types of arrhythmia, and holter recordings are performed to observe changes in ECG morphology due to activity, position changes, circadian cycles etc. The data is saved and used in the development of the ISSD.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
June 2017
Last Updated
8 years ago
Study Type
Observational

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Candidate for ICD implantation
  • Candidate for EP study
  • Candidate for 24 hour holter monitor recording

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

successful recording of Electrocardiogram (ECG) from a patient containing arrhythmia

Time Frame: immediate

recorded Electrocardiogram (ECG) of patients with as many arrhythmia events as possible, preferably tachy-arrhythmia events such as fast VT, flutter or VF

Study Sites (1)

Loading locations...

Similar Trials